Novel inhibitors of human histone deacetylases: Design, synthesis and bioactivity of 3-alkenoylcoumarines - Université de Lorraine Access content directly
Journal Articles Bioorganic and Medicinal Chemistry Letters Year : 2014

Novel inhibitors of human histone deacetylases: Design, synthesis and bioactivity of 3-alkenoylcoumarines

Abstract

Histone deacetylases (HDACs) are well-established, promising targets for anticancer therapy due to their critical role in cancer development. Accordingly, an increasing number of HDAC inhibitors displaying cytotoxic effects against cancer cells have been reported. Among them, a large panel of chemical structures was described including coumarin-containing molecules. In this study, we described synthesis and biological activity of new coumarin-based derivatives as HDAC inhibitors. Among eight derivatives, three compounds showed HDAC inhibitory activities and antitumor activities against leukemia cell lines without affecting the viability of peripheral blood mononuclear cells from healthy donors.
No file

Dates and versions

hal-01494600 , version 1 (23-03-2017)

Identifiers

Cite

Carole Seidel, Michael Schnekenburger, Clemens Zwergel, François Gaascht, Antonello Mai, et al.. Novel inhibitors of human histone deacetylases: Design, synthesis and bioactivity of 3-alkenoylcoumarines. Bioorganic and Medicinal Chemistry Letters, 2014, 24 (16), pp.3797 - 3801. ⟨10.1016/j.bmcl.2014.06.067⟩. ⟨hal-01494600⟩
91 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More